Vicarious Surgical Income Statement (2020-2025) | RBOT

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating items
Research & Development (Quarter)
3.61M4.01M5.19M9.26M9.85M10.05M12.12M11.88M13.36M12.71M13.04M8.47M9.97M10.92M10.80M8.46M9.41M9.05M7.99M
Selling, General & Administrative (Quarter)
1.40M2.28M2.53M7.00M6.93M7.76M8.13M6.89M7.00M7.08M6.91M5.87M5.00M5.59M5.75M5.54M5.29M4.12M3.16M
Restructuring Costs (Quarter)
0.13M1.51M
Other Operating Expenses (Quarter)
0.10M0.33M0.84M1.57M-0.11M1.31M1.91M1.84M1.96M1.67M-19.95M1.20M1.14M1.20M1.21M54.84M1.04M0.35M-11.60M
Operating Expenses (Quarter)
5.23M6.61M8.56M17.82M18.18M19.13M22.16M20.61M22.32M21.46M0.00M15.54M16.11M17.71M17.75M68.83M15.75M13.52M-0.45M
Operating Income (Quarter)
-5.23M-6.61M-8.56M-17.82M-18.18M-19.13M-22.16M-20.61M-22.32M-21.46M-21.35M-15.54M-16.11M-17.71M-17.75M-14.98M-15.75M-13.52M-11.50M
EBIT (Quarter)
-5.23M-6.61M-8.56M-17.82M-18.18M-19.13M-22.16M-20.61M-22.32M-21.46M-21.35M-15.54M-16.11M-17.71M-17.75M-14.98M-15.75M-13.52M-11.50M
Non-operating items
Non Operating Investment Income (Quarter)
0.07M0.01M0.07M-0.20M0.04M0.10M-0.05M-0.01M0.17M-0.07M-0.03M-0.02M
Interest & Investment Income (Quarter)
0.00M0.00M-0.00M0.02M0.01M0.10M0.49M0.83M1.47M1.04M0.95M0.97M0.97M0.92M0.80M0.59M0.45M0.26M0.16M
Other Non Operating Income (Quarter)
-19.57M-1.59M0.09M-0.04M
Non Operating Income (Quarter)
0.35M
Net income details
EBT (Quarter)
-5.23M-6.64M-45.12M21.79M42.53M-1.45M-24.74M-11.18M-26.92M-15.33M-15.70M-13.11M-17.00M-15.21M-17.09M-13.93M-15.39M-13.21M-11.06M
Profit After Tax (Quarter)
-5.23M-6.64M-45.12M21.79M42.53M-1.45M-24.74M-11.18M-26.92M-15.33M-15.70M-13.11M-17.00M-15.21M-17.09M-13.93M-15.39M-13.21M-11.06M
Income from Non-Controlling Interests (Quarter)
-21.03M
Income from Continuing Operations (Quarter)
-5.23M-6.64M-45.12M21.79M42.53M-1.45M-24.74M-11.18M-26.92M-15.33M-15.70M-13.11M-17.00M-15.21M-17.09M-13.93M-15.39M-13.21M-11.06M
Consolidated Net Income (Quarter)
-5.23M-6.64M-45.12M21.79M42.53M-1.45M-24.74M-11.18M-26.92M-15.33M-15.70M-13.11M-17.00M-15.21M-17.09M-13.93M-15.39M-13.21M-11.06M
Income towards Parent Company (Quarter)
-5.23M-6.64M-45.12M21.79M42.53M-1.45M-24.74M-11.18M-26.92M-15.33M-15.70M-13.11M-17.00M-15.21M-17.09M-13.93M-15.39M-13.21M-11.06M
Net Income towards Common Stockholders (Quarter)
-5.23M-6.64M-45.12M21.79M42.53M-1.45M-24.74M-11.18M-26.92M-15.33M-15.70M-13.11M-17.00M-15.21M-17.09M-13.93M-15.39M-13.21M-11.06M
Additional items
EPS (Basic) (Quarter)
-0.06-0.08-0.490.280.35-0.01-0.20-0.10-0.21-3.62-3.04-1.83-2.90-2.59-2.90-2.35-2.60-2.23-1.86
EPS (Weighted Average and Diluted) (Quarter)
-0.06-0.08-0.490.33-0.01-0.20-0.21-0.12-3.04-1.83-2.90-2.59-2.90-2.35-2.60-2.23-1.86
Shares Outstanding (Weighted Average) (Quarter)
87.51M87.68M92.23M96.69M120.28M120.81M121.97M121.79M126.13M4.22M5.17M27.65M5.86M5.87M5.88M27.65M5.92M27.65M27.65M27.65M
EBITDA (Quarter)
-5.23M-6.61M-8.56M-17.82M42.53M-1.45M-24.74M-11.18M-26.86M-15.53M-15.66M-13.01M-17.05M-15.21M-16.92M-14.00M-15.43M-13.23M-11.05M
Interest Expenses (Quarter)
0.01M0.01M0.01M0.03M0.03M0.03M-0.01M0.00M0.00M0.00M0.02M
Shares Outstanding (Quarter)
66.55M66.55M118.62M119.77M121.17M121.63M122.34M4.20M4.22M4.24M5.83M5.85M5.87M5.88M5.91M5.92M5.93M5.95M5.96M7.12M